STARKAP: Dostarlimab Tested for Resistant Kaposi’s
In a groundbreaking step toward addressing the challenges faced by people living with HIV (PLWH) who develop Kaposi’s Sarcoma (KS), researchers have unveiled the STARKAP protocol—a preliminary assessment probing the safety and tolerability of dostarlimab in treating cART-refractory HIV-associated Kaposi’s Sarcoma. This novel approach combines immune checkpoint inhibition with the ongoing battle against this virally […]
In a groundbreaking step toward addressing the challenges faced by people living with HIV (PLWH) who develop Kaposi’s Sarcoma (KS), researchers have unveiled the STARKAP protocol—a preliminary assessment probing the safety and tolerability of dostarlimab in treating cART-refractory HIV-associated Kaposi’s Sarcoma. This novel approach combines immune checkpoint inhibition with the ongoing battle against this virally […]
What's Your Reaction?
